Bleeding clinical trials in Indiana
7 studies for Bleeding are looking for participants at sites in Indiana.
Cities in Indiana
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
- Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis
RecruitingPhase 3
Ages 12 to 70 · All sexes · Updated Nov 13, 2026 · NCT07935356Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Indiana University, Indianapolis
- Blue Coast Research Center, LLC, Indianapolis
- Franciscan Physician Network, Indiana Heart Physicians, Indianapolis
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07175428Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Profound Research, Advanced Cardiovascular Care + Electrophysiology Clinic, Hobart
- Cardiovascular Research of Northwest Indiana, LLC, Munster
- Profound Research, Powers Health Medical Group - Electrophysiology, Munster
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07626411A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Innovative Hematology, Inc., Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Innovative Hematology, Inc., Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Innovative Hematology, Inc., Indianapolis
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 7, 2026 · NCT05568719A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
- Indiana University, Indianapolis
RecruitingPhase 3
1 Month · All sexes · Updated Jun 30, 2026 · NCT06664775From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.